Adaptive Biotechnologies Corporation Share Price
Stocks
ADPT
US00650F1093
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 31/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 26.64 USD | -5.43% |
|
+4.43% | +64.04% |
| Market Cap | 425.16Cr 380.78Cr 350.25Cr 317.36Cr 593.22Cr 40TCr 604.33Cr 4.18TCr 1.68TCr 21TCr 1.6TCr 1.56TCr 67TCr | P/E 2026 * |
-49.4x | P/E 2027 * | -154x |
|---|---|---|---|---|---|
| Enterprise Value | 396.44Cr 355.05Cr 326.59Cr 295.92Cr 553.15Cr 38TCr 563.5Cr 3.89TCr 1.56TCr 20TCr 1.49TCr 1.46TCr 62TCr | EV / Sales 2026 * |
13.5x | EV / Sales 2027 * | 10.9x |
| Free-Float |
97.95% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ADPT | Delayed | |
CBOE
| ADPT | Real-time | |
|
Deutsche Boerse AG
| 1HM | Delayed | |
|
Boerse Muenchen
| 1HM | Real-time | |
|
Tradegate
| 1HM | Real-time | |
|
Börse Stuttgart
| 1HM | Delayed |
Last Transcript: Adaptive Biotechnologies Corporation
| 1 day | -5.43% | ||
| 1 week | +4.43% | ||
| 1 month | -7.82% | ||
| 3 months | +18.03% | ||
| 6 months | +88.94% | ||
| Current year | +64.04% |
| 1 week | 25.24 |  | 29.05 |
| 1 month | 23.82 | | 30.74 |
| Current year | 12 | | 30.74 |
| 1 year | 12 | | 30.74 |
| 3 years | 2.28 | | 30.74 |
| 5 years | 2.28 | | 37.55 |
| 10 years | 2.28 | | 71.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chad Robins
CEO | Chief Executive Officer | 51 | 08/09/2009 |
Kyle Piskel
DFI | Director of Finance/CFO | 42 | 08/04/2024 |
Julie Rubinstein
PSD | President | 54 | 01/02/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Chad Robins
CHM | Chairman | 51 | - |
Robert Hershberg
BRD | Director/Board Member | 63 | 01/02/2013 |
Peter Neupert
BRD | Director/Board Member | 70 | 01/12/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/10/26 | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 13/10/26 | Exercice | Chairperson | 35,643 | 0.0223% | ||
| 08/10/26 | Exercice | Chairperson | 35,643 | 0.0223% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.43% | +4.43% | +53.46% | +500.00% | 425.16Cr | |
| -0.62% | -1.87% | +42.87% | +64.15% | 6.38TCr | |
| +0.35% | +3.20% | +14.40% | +81.76% | 5.64TCr | |
| +0.53% | +1.96% | +16.24% | +103.35% | 5.46TCr | |
| -2.81% | -4.31% | +23.50% | +47.83% | 4.41TCr | |
| -0.33% | -1.93% | +19.28% | +98.80% | 4.21TCr | |
| +0.55% | +2.31% | +225.14% | +866.21% | 4.1TCr | |
| +3.27% | +47.96% | +112.84% | +96.58% | 3.49TCr | |
| +1.22% | -1.44% | +14.57% | +46.95% | 3.28TCr | |
| +0.89% | +20.55% | -40.62% | +349.24% | 2.47TCr | |
| Average | -0.24% | +7.23% | +48.17% | +225.49% | 3.99TCr | |
| Weighted average by Cap. | +0.12% | +5.43% | +48.05% | +180.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 29Cr 26Cr 24Cr 22Cr 41Cr 2.78TCr 42Cr 288.09Cr 115.65Cr 1.46TCr 110.05Cr 107.71Cr 4.62TCr | 36Cr 32Cr 30Cr 27Cr 50Cr 3.42TCr 51Cr 353.81Cr 142.03Cr 1.8TCr 135.16Cr 132.28Cr 5.67TCr |
| Net income | -8.5Cr -7.62Cr -7Cr -6.35Cr -12Cr -807.35Cr -12Cr -84Cr -34Cr -424.69Cr -32Cr -31Cr -1.34TCr | -2.72Cr -2.44Cr -2.24Cr -2.03Cr -3.8Cr -258.57Cr -3.87Cr -27Cr -11Cr -136.02Cr -10Cr -10Cr -428.94Cr |
| Net Debt | -29Cr -26Cr -24Cr -21Cr -40Cr -2.73TCr -41Cr -282.17Cr -113.27Cr -1.43TCr -107.79Cr -105.5Cr -4.52TCr | -33Cr -30Cr -27Cr -25Cr -46Cr -3.14TCr -47Cr -325.01Cr -130.47Cr -1.65TCr -124.16Cr -121.52Cr -5.21TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/26/30 | $26.64 | -5.43% | 42,56,500 |
| 29/26/29 | $28.17 | -0.70% | 25,88,870 |
| 28/26/28 | $28.37 | +2.57% | 23,17,531 |
| 27/26/27 | $27.66 | +5.29% | 15,35,602 |
| 26/26/26 | $26.27 | +2.98% | 11,64,557 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ADPT Stock
Select your edition
All financial news and data tailored to specific country editions
